Preventive diabetology at the turn of the centuries. Prevention of type 2 diabetes mellitus: achievements and prospects


  • G.F. Gendeleka Odessa National Medical University, Odesa, Ukraine
  • A.N. Gendeleka Municipal Non-Profit Enterprise “Primary Health Care Centre 5”, Odesa, Ukraine



type 2 diabetes mellitus, prevention, prediction strategies, impaired glucose tolerance, lifestyle modification


This article presents the key achievements in the field of diabetes mellitus prevention. Currently, various researches have been conducted on the prevention of diabetes mellitus, with different designs, types of intervention, duration of follow-up and mechanisms of action. One of the possible mechanisms is aimed to slow down the rate of the peak prevalence of the diabetes mellitus. The second possibility is concerned the majority of medical interventions conducted, which enable to decrease the rate of impaired glucose tolerance in manifestation of diabetes mellitus. The third preventive mo­del consists in a strong stabilization of glucose tolerance. After detection of pre-conditions, which result in diabetes mellitus, preventive methods should be tested for 10–12 years, while beta cells are functionally active.


Download data is not yet available.


American Diabetes Association. Prevention of Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes - 2018. Diabetes Care. 2018 Jan;41(Suppl 1):S51-S54. doi: 10.2337/dc18-S005.

Chiasson JL, Josse RG, Gomis R, et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet. 2002 Jun 15;359(9323):2072-7. doi: 10.1016/S0140-6736(02)08905-5.

Diabetes Prevention Program Research Group. Effects of withdrawal from metfromin on the development of diabetes in the diabetes prevention program. Diabetes Care. 2003 Apr;26(4):977-80.

Diabetes Prevention Program Research Group, Knowler WC, Fowler SE, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009 Nov 14;374(9702):1677-86. doi: 10.1016/S0140-6736(09)61457-4.

DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators, Gerstein HC, Yusuf S, et al. Effect of rosiglitazone on the frequency of diabetes inpatients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet. 2006 Sep 23;368(9541):1096-105. DOI: 10.1016/S0140-6736(06)69420-8.

Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002 Feb 7;346(6):393-403. doi: 10.1056/NEJMoa012512.

Lindström J, Ilanne-Parikka P, Peltonen M, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006 Nov 11;368(9548):1673-9. doi: 10.1016/S0140-6736(06)69701-8.

Li G, Zhang P, Wang J, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diatetes Prevention Study: a20-year follow-up study. Lancet. 2008 May 24;371(9626):1783-9. doi: 10.1016/S0140-6736(08)60766-7.

NAVIGATOR Study Group, Holmann RR, Haffner SM, et al. Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med. 2010 Apr 22;362(16):1463-76. doi: 10.1056/NEJMoa1001122.

Nichols GA, Hillier TA, Brown JB, et al. Progression from newly acquired impaired fasting glucose to type 2 diabetes. Diabetes Care. 2007 Feb;30(2):228-33. doi: 10.2337/dc06-1392.

Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997 Apr;20(4):537-44.

Knowler WC, Hamman RF, Edelstein SL, Prevention of type 2 diabetes with troglitazone in the diabetes prevention program. Diabetes. 2005 Apr;54(4):1150-6.

Torgerson JS, Hauptman J, Boldrin MN, Sjöström L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomised study of orlistat as an adjunct to lifestyle changes for the

prevention of type 2 diabetes in obese patients. Diabetes Care. 2004 Jan;27(1):155-61.

Tuomilehto J, Lindström J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001 May 3;344(18):1343-50. doi: 10.1056/NEJM200105033441801.



How to Cite

Gendeleka, G., & Gendeleka, A. (2021). Preventive diabetology at the turn of the centuries. Prevention of type 2 diabetes mellitus: achievements and prospects. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), 15(2), 178–185.



Preventive Endocrinology